Latest news with #AuroraCannabis
CNBC
3 days ago
- Business
- CNBC
Lightning Round: Cerence is a winner, says Jim Cramer
'Mad Money' host Jim Cramer weighs in on stocks including: Aurora Cannabis, Skyworks Solutions, Sezzle, Build-A-Bear Workshop, Cerence, Highpeak Energy, and Republic Services.
Yahoo
16-05-2025
- Business
- Yahoo
Rubicon Organics Announces Appointment of Glen Ibbott as Interim CFO
VANCOUVER, British Columbia, May 15, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) ('Rubicon Organics' or the 'Company'), a licensed producer focused on cultivating and selling organic certified and premium cannabis products, today announced the appointment of Glen Ibbott, a cannabis industry veteran and former Chief Financial Officer of Aurora Cannabis Inc. (TSX: ACB, Nasdaq: ACB) as its Interim Chief Financial Officer. Janis Risbin, current CFO, will be stepping away from her full-time role effective today. She will remain in an advisory role over the next few months to ensure a smooth transition of responsibilities to Mr. Ibbott. 'Glen's leadership at Aurora Cannabis helped to build one of the largest cannabis companies in Canada. His expertise comes at an important time for Rubicon Organics as we scale new capacity and explore new markets for our industry leading premium cannabis brands. His strategic insight and financial leadership will be instrumental as we navigate our next phase of growth and innovation,' said Margaret Brodie, CEO. Ms. Brodie continued, "On behalf of our Board of Directors, and the entire Rubicon Organics team, I would like to offer our sincere thanks and appreciation to Janis. Since 2019, Janis has dedicated immeasurable time and energy to Rubicon; and we have been fortunate to have her expertise over the years as we navigated this emerging industry. We wish her all the best for her future endeavours." Mr. Ibbott commented, 'It's an exciting time to join Rubicon Organics. The leading premium cannabis products with more demand than supply, new capacity coming on this year, and certifications in place for international expansion. I believe Rubicon has been a hidden gem in the financial markets that is now ready to shine with the best of the industry.' Glen Ibbott is a seasoned financial executive with over 25 years of leadership experience in publicly-traded life sciences and cannabis companies. He is best known in the industry for his tenure as CFO at Aurora Cannabis from 2017 to 2024, where he played a pivotal role in the company's rapid growth, international expansion, and delivery of recurring EBITDA and cash flow. Prior to Aurora, Mr. Ibbott held senior finance roles at several prominent healthcare and pharmaceutical companies, including QLT Inc., where he was instrumental in its $500 million merger with Aegerion Pharmaceuticals. He began his career at KPMG and holds dual CPA designations in Canada and the U.S., as well as MBAs from Cornell University and Queen's University. His strategic acumen and deep industry knowledge make him a valuable asset in guiding companies through complex financial landscapes. We will be initiating a comprehensive search process to identify a permanent CFO. This process will include both internal and external candidates and will be guided by our commitment to finding a leader with deep financial expertise, a strong understanding of the cannabis industry, and a vision aligned with our long-term strategic goals. ABOUT RUBICON ORGANICS Rubicon Organics Inc. is a global brand leader in premium organic cannabis products. The Company is vertically integrated through its wholly owned subsidiary Rubicon Holdings Corp, a licensed producer. Rubicon Organics is focused on achieving industry leading profitability through its premium cannabis flower, product innovation and brand portfolio management, including three flagship brands: its super-premium brand Simply Bare™ Organic, its premium brand 1964 Supply Co™, and its cannabis wellness brand Wildflower™ in addition to the Company's mainstream brand Homestead Cannabis Supply™. The Company ensures the quality of its supply chain by cultivating, processing, branding and selling organic certified, sustainably produced, super-premium cannabis products from its state-of-the-art glass roofed facility located in Delta, BC, Canada. CONTACT INFORMATION Rubicon Organics Brodie, CEOPhone: +1 (437) 929-1964Email: ir@ West Hastings StreetVancouver, BC V6C 1A5 The TSX Venture Exchange or its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) does not accept responsibility for the adequacy or accuracy of this press release. Cautionary Statement Regarding Forward Looking Information This press release contains forward-looking information within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, statements regarding Rubicon Organics' goal of achieving industry leading profitability are 'forward-looking statements'. Forward-looking information can be identified by the use of words such as 'will' or variations of such word or statements that certain actions, events or results 'will' be taken, occur or be achieved. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward looking statements. The forward-looking information in this press release is based on certain assumptions that management considers reasonable under the circumstances. These statements are based on current expectations, estimates, and projections about the Company's business and the industry in which it operates. Risks and uncertainties associated with the forward-looking information in this press release include, among others, risks related to the recently completed Offering, including that the Company does not use the proceeds from the Offering as anticipated, risks related to regulatory approvals, changes in market conditions, competition, supply chain disruptions, the Company's ability to maintain certification standards, and the successful implementation of its business strategy. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. Although Rubicon Organics has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. Rubicon Organics assumes no obligation to update any forward-looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.
The Market Online
02-05-2025
- Business
- The Market Online
Cannabis Report: Breathalyzers, record cash flow, & the funk
An innovator in cannabis and alcohol breathalyzers, signed a non-exclusive North American distribution agreement with Alco Prevention Canada. The agreement covers an autonomous alcohol breathalyzer devices, whose patent pending pre-calibrated cartridge system promises to save time and money associated with calibration equipment and site visits from technicians. (Source: Cannabix Technologies) Click here for the full story. 1 | Aurora Cannabis completes multimillion dollar investment and renaming of B.C. manufacturing facility 2 | SNDL reports record gross margin and positive cash flow in Q1 2025 3 | Hall of Fame music icon George Clinton to launch 'The FUNK' by Khalifa Kush Top Cannabis Stocks Apr. 25 to May. 02, 2025 1. | 5,763 views | Canopy Growth Corp. 2. | 5,521 views | Medipharm Labs Corp. 3. | 5,387 views | Tilray Brands Inc. 4. | 4,104 views | Curaleaf Holdings Inc. 5. | 730 views | Organigram Holdings Inc. 6. | 514 views | Aurora Cannabis Inc. The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
Yahoo
07-02-2025
- Business
- Yahoo
Aurora Cannabis Announces Supply Agreement with SNDL
NASDAQ | TSX: ACB Agreement Complements Existing Relationship Focused on the Supply of Premium Cannabis EDMONTON, AB, February 6, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB) –the Canadian based leading global medical cannabis company, is pleased to announce a strategic supply agreement (the "Agreement") with SNDL Inc. ("SNDL"), a Canadian licensed producer and vertically integrated cannabis enterprise. Under this Agreement, SNDL is expected to supply Aurora with premium cannabis flower product grown at SNDL's indoor facility in Atholville, New Brunswick. The term of the agreement is for three years with an option to extend and an estimated value of $27 million. Aurora and SNDL have an existing and successful supply relationship for the manufacturing of various cannabis products and input material. "Following our strong, third quarter performance driven by record setting growth in our international medical cannabis segment, Aurora remains focused on a balanced approach to operating a hybrid manufacturing network of in-house and third-party cultivation. We value our relationship with SNDL and their shared commitment to cultivation excellence," said Miguel Martin, Executive Chairman and Chief Executive Officer of Aurora Cannabis. "As Canada's leading integrated cannabis company, SNDL is well positioned as a supplier of quality cannabis products to commercial partners like Aurora. We have a shared approach to quality and cultivation excellence and look forward to expanding this relationship further," said Zach George, Chief Executive Officer of SNDL. About Aurora Cannabis Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe and Australia. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company's adult- use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched. Learn more at and follow us on X and LinkedIn. Aurora's Common Shares trade on the NASDAQ and TSX under the symbol "ACB". Contact For Investors: ICR, Inc. | aurora@ Forward Looking Information This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements made in this news release include, but are not limited to, statements regarding the Company's supply agreement and relationship with SNDL, including but not limited to the contract term and expected value, expectations related to the supply of flower product from SNDL and the Company's focus on a balanced approach to operating a hybrid manufacturing network of in-house and third-party cultivation. These forward-looking statements are only predictions. Forward looking information or statements contained in this news release have been developed based on assumptions management considers to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of third party government and non-government consumer sales channels, management's estimates of consumer demand in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the risk of successful integration of acquired business and operations (with respect to the Transaction and more generally with respect to future acquisitions), management's estimation that SG&A will grow only in proportion of revenue growth, the ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crises and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's annual information from dated June 20, 2024 (the "AIF") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR+ at and filed with and available on the SEC's website at The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law. View original content to download multimedia: SOURCE Aurora Cannabis Inc. View original content to download multimedia: Sign in to access your portfolio
Yahoo
06-02-2025
- Business
- Yahoo
Aurora Cannabis Third Quarter 2025 Earnings: EPS: CA$0.57 (vs CA$0.51 loss in 3Q 2024)
Revenue: CA$88.2m (up 37% from 3Q 2024). Net income: CA$31.6m (up from CA$24.2m loss in 3Q 2024). Profit margin: 36% (up from net loss in 3Q 2024). EPS: CA$0.57 (up from CA$0.51 loss in 3Q 2024). All figures shown in the chart above are for the trailing 12 month (TTM) period Looking ahead, revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 8.2% growth forecast for the Pharmaceuticals industry in Canada. Performance of the Canadian Pharmaceuticals industry. The company's shares are up 38% from a week ago. Our analysis of Aurora Cannabis based on 6 different valuation metrics shows it might be undervalued. Click here to find out what a fair price for the stock might be and where analysts see the share price heading over the next year. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
